NCT02231177View on ClinicalTrials.gov

Pharmacokinetics and Safety of BI 1744 CL Plus Tiotropium Bromide in Chronic Obstructive Pulmonary Disease (COPD)

PHASE1CompletedINTERVENTIONAL
Enrollment

47

Participants

Timeline

Start Date

June 30, 2008

Primary Completion Date

November 30, 2008

Conditions
Pulmonary Disease, Chronic Obstructive
Interventions
DRUG

BI 1744 CL

DRUG

BI 1744 CL/Tiotropium FDC

DRUG

Tiotropium

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY

NCT02231177 - Pharmacokinetics and Safety of BI 1744 CL Plus Tiotropium Bromide in Chronic Obstructive Pulmonary Disease (COPD) | Biotech Hunter | Biotech Hunter